![Western Blot: SCL/Tal1 Antibody [25610002] - Samples: Lane 1, Marker [kDa]: 250, 130, 95, 72, 55, 36, 28, 17, 11 Lane 2, RT-4 Lane 3, U-251MG sp Lane 4, Human Plasma Lane 5, Liver Lane 6, Tonsil, Target weight [kDa]: 34 Validation score: 2 Validation description: Supportive - Band of predicted size in kDa (+/-20%) with additional bands present.](http://images.novusbio.com/fullsize/SCL-Tal1-Antibody-Western-Blot-25610002-img0002.jpg "Western Blot: SCL/Tal1 Antibody [25610002] - Samples: Lane 1, Marker [kDa]: 250, 130, 95, 72, 55, 36, 28, 17, 11 Lane 2, RT-4 Lane 3, U-251MG sp Lane 4, Human Plasma Lane 5, Liver Lane 6, Tonsil, Target weight [kDa]: 34 Validation score: 2 Validation description: Supportive - Band of predicted size in kDa (+/-20%) with additional bands present.")
| Immunogen | This antibody is specific for the N Terminus Region of the target protein. |
| Specificity | This product is specific for Human TAL1. |
| Isotype | IgG |
| Clonality | Polyclonal |
| Host | Rabbit |
| Gene | TAL1 |
| Purity | Immunogen affinity purified |
| Innovator's Reward | Test in a species/application not listed above to receive a full credit towards a future purchase. |
| Dilutions |
|
|
| Application Notes | This antibody is useful in ELISA, Immunohistochemistry-Paraffin and Western Blot. |
|
| Publications |
|
| Storage | Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. |
| Buffer | 20mM Potassium Phosphate (pH 7.0) and 0.15M NaCl |
| Preservative | No Preservative |
| Purity | Immunogen affinity purified |
![Neutralization VEGFR2/KDR/Flk-1 Antibody [Unconjugated]](https://images.novusbio.com/images2/VEGF_R2_AF644_Block_Neutralize_1519.jpg)
![Immunohistochemistry VEGFR2/KDR/Flk-1 Antibody [Unconjugated]](https://images.novusbio.com/images2/VEGF_R2_AF644_Immunohistochemistry_22159.jpg)
![Immunohistochemistry VEGFR2/KDR/Flk-1 Antibody [Unconjugated]](https://images.novusbio.com/images2/VEGF_R2_AF644_Immunohistochemistry_6888.jpg)
Secondary Antibodies |
Isotype Controls |
Research Areas for SCL/Tal1 Antibody (25610002)Find related products by research area.
|
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
![Immunohistochemistry: SCL/Tal1 Antibody [25610002] - A majority of the normal cells showed moderate cytoplasmic positivity with additional nuclear positivity in few cases. Strong cytoplasmic positivity was seen in Purkinje cells and strong nuclear staining in bone marrow poetic cells. Hepatocytes showed moderate nuclear staining. Squamous epithelia and lymphoid tissues in general were negative or weakly stained. Most of the malignant cells were weakly stained or negative. Few cases of ovarian, endometrial and liver cancers displayed moderate cytoplasmic positivity with additional nuclear immunoreactivity in some cases. Lymphomas were all negative. Image and statement courtesy of the Human Protein Atlas (HPA).](http://images.novusbio.com/fullsize/SCL-Tal1-Antibody-Immunohistochemistry-25610002-img0001.jpg "Immunohistochemistry: SCL/Tal1 Antibody [25610002] - A majority of the normal cells showed moderate cytoplasmic positivity with additional nuclear positivity in few cases. Strong cytoplasmic positivity was seen in Purkinje cells and strong nuclear staining in bone marrow poetic cells. Hepatocytes showed moderate nuclear staining. Squamous epithelia and lymphoid tissues in general were negative or weakly stained. Most of the malignant cells were weakly stained or negative. Few cases of ovarian, endometrial and liver cancers displayed moderate cytoplasmic positivity with additional nuclear immunoreactivity in some cases. Lymphomas were all negative. Image and statement courtesy of the Human Protein Atlas (HPA).")
![ELISA: SCL/Tal1 Antibody [25610002]](http://images.novusbio.com/fullsize/SCL-Tal1-Antibody-ELISA-25610002-img0003.jpg "ELISA: SCL/Tal1 Antibody [25610002]")
![Immunocytochemistry LMO2 Antibody [Unconjugated]](https://images.novusbio.com/images2/LMO2_AF2726_Immunocytochemistry_10616.jpg)
![Flow Cytometry LMO2 Antibody [Unconjugated]](https://images.novusbio.com/images2/LMO2_AF2726_Flow_Cytometry_22133.jpg)
![Flow Cytometry LMO2 Antibody [Unconjugated]](https://images.novusbio.com/images2/LMO2_AF2726_Flow_Cytometry_22134.jpg)
![Western Blot TCF-3/E2A Antibody (826927) [Unconjugated]](https://images.novusbio.com/images2/TCF3_MAB7650_Western_Blot_12841.jpg)
![Immunohistochemistry TCF-3/E2A Antibody (826927) [Unconjugated]](https://images.novusbio.com/images2/TCF3_MAB7650_Immunohistochemistry_12859.jpg)
![Western Blot GATA-2 Antibody [Unconjugated]](https://images.novusbio.com/images2/GATA-2_AF2046_Western_Blot_5163.jpg)
![Simple Western GATA-2 Antibody [Unconjugated]](https://images.novusbio.com/images2/GATA2_AF2046_Simple_Western_16938.jpg)
![Western Blot GATA-2 Antibody [Unconjugated]](https://images.novusbio.com/images2/GATA2_AF2046_Western_Blot_22630.jpg)
![Immunohistochemistry CD34 Antibody [Unconjugated]](https://images.novusbio.com/images2/CD34_AF4117_Immunohistochemistry_6824.jpg)
![N/A Erythropoietin/EPO [HRP]](https://images.novusbio.com/images2/DATA_Erythropoietin_MEP00_ELISA_970.jpg)
![N/A Erythropoietin/EPO [HRP]](https://images.novusbio.com/images2/Erythropoietin_MEP00_ELISA_421.jpg)
![N/A VEGF [HRP]](https://images.novusbio.com/images2/DATA_VEGF_DVE00_ELISA_871.jpg)
![N/A VEGF [HRP]](https://images.novusbio.com/images2/DATA_VEGF_DVE00_ELISA_872.jpg)
![N/A VEGF [HRP]](https://images.novusbio.com/images2/VEGF_DVE00_ELISA_208.jpg)